Aldesleukin Completed Phase 1 Trials for X-linked Thrombocytopenia / Wiskott-Aldrich Syndrome (WAS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00774358Interleukin-2 Treatment for Wiskott-Aldrich Syndrome